US Stock MarketDetailed Quotes
ARTV Artiva Biotherapeutics
- 13.070
- -0.310-2.32%
Close Nov 12 16:00 ET
- 13.070
- 0.0000.00%
Post 16:20 ET
317.43MMarket Cap-9761P/E (TTM)
13.520High12.410Low62.21KVolume13.140Open13.380Pre Close803.85KTurnover0.45%Turnover RatioLossP/E (Static)24.29MShares17.31052wk High-1.66P/B181.93MFloat Cap9.68052wk Low--Dividend TTM13.92MShs Float17.310Historical High--Div YieldTTM8.30%Amplitude9.680Historical Low12.921Avg Price1Lot Size
About Artiva Biotherapeutics Company
Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.
Company Profile
SymbolARTV
Company NameArtiva Biotherapeutics
Listing DateJul 19, 2024
Issue Price12.00
Founded2019
CEODr. Fred Aslan, M.D.
MarketNASDAQ
Employees81
Fiscal Year Ends12-31
Address5505 Morehouse Drive,Suite 100
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-267-4467
Websitehttp://www.artivabio.com
Company Executives
- Name
- Position
- Salary
- Dr. Fred Aslan, M.D.
- President, Chief Executive Officer and Director
- 1.11M
- Neha Krishnamohan
- Executive Vice President, Corporate Development, Chief Financial Officer and Principal Accounting Officer
- --
- Thorsten Graef, M.D.,PhD
- Chief Medical Officer
- --
- Christopher Horan
- Chief Technical Operations Officer
- 726.90K
- Jennifer Kinsbruner Bush
- Chief Operating Officer, Chief Legal Officer, Corporate Secretary and Compliance Officer
- 725.83K
- Dr. Heather Raymon, PhD
- Senior Vice President, Research and Early Development
- --
- Dr. Brian Daniels,M.D.
- Chairman of the Board
- --
- James Jong-eun Park
- Director
- --
- Yong-Jun Huh
- Director
- --
- Dr. Alison Moore, PhD
- Director
- --
- Dr. Diego Miralles, M.D.
- Director
- --
- Dr. Laura Stoppel, PhD
- Independent Director
- --
- Dr. Yvonne Yamanaka, PhD
- Independent Director
- --
- Dr. Laura Bessen, M.D.
- Independent Director
- --
- Elizabeth L. Hougen
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
